Athelas Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 115
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $59.4M
Latest Deal Amount
  • Investors
  • 22

Athelas General Information

Description

Developer of an in-home blood diagnostic device designed to monitor the immune system from a drop of blood. The company's device is a portable optical unit for sample imaging, analyzes blood cells, and generates diagnostic reports, enabling patients to keep a check on their immunity level from home and helping the doctors to identify leukemia, infections, and inflammatory diseases early.

Contact Information

Website
www.athelas.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Devices and Supplies
Primary Office
  • 160 South Whisman Road
  • Mountain View, CA 94041
  • United States
+1 (833) 000-0000

Athelas Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Athelas Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 31-Jan-2022 $59.4M 00000 00.000 Completed Generating Revenue
6. Later Stage VC (Series B) 16-Apr-2021 000.00 000.00 00000 Completed Generating Revenue
5. Early Stage VC (Series A) 01-Jan-2018 000.00 000.00 000.00 Completed Generating Revenue
4. Early Stage VC (Series A) 23-Aug-2016 00.00 00.000 000.00 Completed Generating Revenue
3. Accelerator/Incubator 01-May-2016 00000 00000 00.000 Completed Generating Revenue
2. Grant 18-Oct-2015 $32K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2015 Completed Generating Revenue
To view Athelas’s complete valuation and funding history, request access »

Athelas Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B-1 Prime 0,000 00.000000 00 000.00 000.00 00 000.00 0.000
Series B Prime 000,000 00.000000 00 0000.00 0000.00 00 0000.00 0.000
Series B-1 00,000 00.000000 00 000.00 000.00 00 000.00 0.000
Series B 000,000 00.000000 00 000.00 000.00 00 000.00 0.000
Series A-5 00,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A-4 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series A-3 00,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A-2 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A-1 10,580 $0.000100 6% $9.45 $9.45 1x $9.45 0.11%
Series A 515,632 $0.000100 6% $27.15 $27.15 1x $27.15 5.36%
To view Athelas’s complete cap table history, request access »

Athelas Patents

  • 2

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Athelas Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20190247851-A1 Capillary-loaded analysis device for biological fluid samples Abandoned 12-Feb-2018 000000000000
US-20180211380-A1 Classifying biological samples using automated image analysis Abandoned 25-Jan-2017 0000000000 00

Athelas Executive Team (3)

Name Title Board Seat Contact Info
Tanay Tandon Co-Founder & Chief Executive Officer
Dhruv Parthasarathy Chief Technology Officer
Deepika Bodapati Co-Founder
To view Athelas’s complete executive team members history, request access »

Athelas Board Members (3)

Name Representing Role Since
Alfred Lin Sequoia Capital Board Observer 000 0000
Arjun Sethi Tribe Capital Board Observer 000 0000
Hemant Taneja General Catalyst Board Member 000 0000
To view Athelas’s complete board members history, request access »

Athelas Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Athelas Investors (22)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Greenoaks Capital Partners Venture Capital Minority 000 0000 000000 0
General Catalyst Venture Capital Minority 000 0000 000000 0
Human Capital Venture Capital Minority 000 0000 000000 0
Shasta Ventures Venture Capital Minority 000 0000 000000 0
Tribe Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 22 investors. Get the full list »

Ready to get started?

Request a free trial